Replies to post #13009 on Plandai Biotechnology Inc (PLPL)

[Tonyeight]

looking good here for huge mj play
Plandai Biotechnology, Inc. (PLPL.OB) Submits Request To South African Legislature To Permit Cannabis Research


inShare


3/25/2014 8:56:58 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEATTLE, WA--(Marketwired - March 24, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced the submission of a request for ministerial dispensation to the Secretary of Parliament of South Africa to permit cannabis research in South Africa for medicinal purposes. Dr. Mario Oriani-Ambrosini, a South African legislator battling terminal cancer, recently introduced legislation to permit medical marijuana research and usage that has generated a groundswell of popular support and led to the formation of The Cancer Treatment Campaign.

Dr. Oriani-Ambrosini, who has incurable cancer of the pleura, has sought inter alia via the Medical Innovations Bill to legalize the medicinal and industrial applications of the cannabis plant. Plandaí and the Cancer Treatment Campaign, together with Dr. Oriani-Ambrosini, are seeking a special ministerial dispensation to pursue methods of delivering a clinical dose of non-psychoactive nano-particle cannabinoid molecules. The proposed collective collaborative research project will be conducted by the universities of Cape Town, Mississippi, Alabama and North West, Potchefstroom, making this a uniquely African-American fight against the world scourge of cancer.

Plandaí's live-plant extraction process recovers phytonutrients from plant material in a mainly nano particle form and rearranges the antioxidants (polyenes) into a format bio-compatible with humans and animals. In addition, through Plandaí's agreement with North West University, South Africa, the company holds the world license to the Pheroid® patented entrapment system to deliver protected Phytofare™ antioxidants to the white blood cells. The result of these two combined technologies is the ability to finally deliver a clinical, pharmaceutical grade dose of cannabinoids to human tissues, thereby unlocking the promise of using natural products to fight many of mankind's most elusive and deadly diseases.

Apart from the well-known medical benefits of cannabis, such as reducing nausea, improving appetite, and reducing anxiety, cannabinoids have shown promise in multiple studies for treating various cancers, epilepsy, pain relief, and in neurological diseases including Alzheimer's, Parkinson's, dementia, and Multiple Sclerosis.

[Aston Martin]

PLPL = Dead end street game for shareholder of the beginning. They will lose big time as well as newbies who believe in those two penny scams - even sub-sub-penny-billion-shares-scam. Those who blame me for been a whiner and for calling this truth should be ashamed:PLPL and TXTM did not prove ANYTHING serious within years by a questionable managements and bad reputation, but those shall be great companies and stories? poor!